Brief: Automodular Announces Receipt Of Interim Order For Proposed Transaction With HLS Therapeutics
Feb 2 (Reuters) - Automodular Corp AMh.V :
* AUTOMODULAR CORPORATION ANNOUNCES RECEIPT OF INTERIM ORDER
FOR
PROPOSED TRANSACTION WITH HLS THERAPEUTICS INC.
Source text for Eikon: ID:nCCNkK6H8a
Further company coverage: AMh.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsCanada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group
Canada's HLS Therapeutics Q1 revenue rises on Vascepa growth, reaffirms 2026 guidance
Canada's HLS Therapeutics Q4 revenue slightly beats on Vascepa strength
Brief: Esperion Partner announces HLS Therapeutics received approval Of NILEMDO for the reduction of LDL-cholesterol in canadians at risk of cardiovascular disease
Brief: HLS Therapeutics announces Health Canada approval of NILEMDO for the reduction of LDL-Cholesterol in Canadians at risk of cardiovascular disease